Navigation Links
Stem cells take cues from fluid in the brain
Date:3/11/2011

sulin-like growth factor or Igf2, which is known to help stem cells multiply and differentiate. Notably, the protein isn't elevated after birth. When the authors blocked Igf2, stem cells in the brain stopped making brain cells, which resulted in abnormally tiny mice brains. And when the team placed brain stem cells in a dish filled with Igf2-rich, embryonic cerebrospinal fluid, the cells proliferated rapidly. "This was clearly the environment the stem cells needed to be happy," LaMantia explains.

Brain cell proliferation is only a good thing when the time is right, however. After all, unrestrained cell multiplication leads to tumors. According to this report, Igf2 knows it's time to activate in the fluid because of proteins in long cells that surround the fluid. These long glial cells stretch from the inner part of the brain, where the fluid is, to its outer layer. They form early in brain development, and younger brain cells crawl along them during development as they find their appropriate positions like patrons filing into an opera house. At the innermost-end of the cells, at a spot called the apical domain, two proteins regulate Igf2 by altering other proteins at the surface of the glial cells, which bind to Ifg2.

If one of the steps in this pathway goes awry, Ifg2 could be activated at the wrong time causing uncontrolled proliferation. Indeed, brain cancer patients with the worst prognosis appear to have the highest levels of Igf2.

However, the fact that vital signals are sent from cerebrospinal fluid could be good news for cancer patients. "It's difficult to deliver a drug that will influence a specific spot within the brain tissue," says LaMantia. Instead, clinicians might one day infuse brain fluid with medicine possibly one that blocks the signals from Igf2 telling cells to proliferate. "The possibilities for using the fluid as an efficient mechanism to deliver small molecule drugs are endless," he says.

Stem cell researchers now have ano
'/>"/>

Contact: Anne Banner
abanner@gwumc.edu
202-994-2261
George Washington University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. UTHealth study: Stem cells may provide treatment for brain injuries
2. Trapping prostate cancer cells to keep them from spreading provides hope
3. NYSCF - Robertson investigator publishes research to better understand pluripotent stem cells
4. New Sweetness Detectors Found in Human Taste Cells
5. UCLA researchers use nano-Velcro technology to improve capture of circulating cancer cells
6. Transplanting umbilical cord and menstrual blood-derived stem cells offer hope for disorders
7. Scientists Use Stem Cells, Skin Cells to Create Brain Cells Lost to Alzheimers
8. Human stem cells transformed into key neurons lost in Alzheimers
9. A small subset of normal white blood cells gives rise to a rare leukemia, study shows
10. WSU researcher creates patented personalized therapy that causes cancer cells to kill themselves
11. Human stem cells from fat tissue fuse with rat heart cells and beat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... scientists report that rats exposed to high-energy particles, simulating ... mission, show lapses in attention and slower reaction times, ... dose ranges. , The cognitive impairments which affected ... animals appear to be linked to protein changes ... found to hold true in humans, suggest it may ...
(Date:4/23/2014)... of the gastro-intestinal tract has long been considered to ... the Sahlgrenska Academy have used refined microscopic techniques that ... surface of the gastro-intestinal tract is only as large ... , The digestive tract, which passes from the mouth ... a length of about 5 meters in a normal ...
(Date:4/23/2014)... 2014) The American Gastroenterological Association (AGA) Research ... Research Scholars. The AGA Research Scholar Awards program, ... independent and productive research careers in digestive diseases. ... an additional year allowing for three consecutive years ... junior faculty who are paving the way for ...
(Date:4/23/2014)... 21, 2014 Five for-profit and non-profit organizations ... million in Proof of Concept grants to accelerate ... commercial products, the Life Sciences Discovery Fund (LSDF) ... Mentoring Program grant to the Washington Biotechnology & ... network to train the next generation of entrepreneurs ...
(Date:4/23/2014)... published in the journal Oncotarget , explored ... appearances or their own DNA signatures within the ... to design effective, targeted treatment strategies. , Firstly ... mutation and either the KRAS or BRAF mutation. ... the EGFR gene mutation have that specific mutation ...
Breaking Medicine News(10 mins):Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
... THE MARKET FORECAST FOR THE DRUG, WALTHAM, Mass., ... Resources, is available to discuss the impact of the ... the,first integrase inhibitor drug which blocks the ability of ... Integrase inhibitors are a novel class of HIV drugs ...
... New products, a growing world,population expected to ... as the,aging of that population, will push anesthesia ... according to Anesthesia Drugs: Worldwide Markets, a,new report ... surgical procedures required anesthetic,administration worldwide in 2006, and ...
... SYK ) disclosed today that the United ... inquiry of the Company regarding possible,violations of the ... sale,of medical devices in certain foreign countries. Stryker ... Commission regarding this,informal investigation. Stryker Corporation is ...
... 118 patients with portal vein thrombosis, noncirrhotic and nontumoral ... well tolerated bleed. Cirrhosis and tumor related portal vein ... state as a cause of portal vein thrombosis is ... number of patients. , A research article to be ...
... health information program recognized for helping to reduce, ... self-care., INDIANAPOLIS, Oct. 12 WellPoint NextRx, ... has received a 2007,Disease Management Leadership Award from ... innovative, Web-based Health Envelope(R) Program.,WellPoint NextRx is owned ...
... /Xinhua-PRNewswire-FirstCall/ -- China,Medicine Corporation ("CMC") (OTC ... prescription and over the counter pharmaceutical ... of Chinese herbs),Chinese herbs, nutritional supplements, ... today announced the Company,s ADTZ,(Aflatoxin-detoxifizyme) project ...
Cached Medicine News:Health News:Impending FDA Approval Decision on the First HIV Integrase Inhibitor Can Have Significant Impact for Patients 2Health News:Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase 2Health News:Portal vein thrombosis is common in extraportal vein obstruction 2Health News:WellPoint NextRx Receives National Leadership Award for Innovative Web Tool 2Health News:WellPoint NextRx Receives National Leadership Award for Innovative Web Tool 3Health News:China Medicine's ADTZ Project Has Been Selected as One of Six Patent Commercialization Projects in Guangdong Province 2
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, Inc ... of less invasive, miniaturized circulatory support technologies that are ... that it expects revenues for the fourth quarter of ... 2013 revenues to approximately $208 million. "Our ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... April 13, 2011 Cephalon, Inc. (Nasdaq: ... CXS Holdings Pty Ltd (Cephalon), has lodged the offer ... for ChemGenex Pharmaceuticals Limited (ASX: CXS) (ChemGenex) with the ... offering a 58 percent premium to the one-month volume ...
... Pharmaceuticals, Inc., the leader in the development of neurosteroids ... of a $3 million grant by the U.S. Department ... the treatment of Fragile-X Syndrome (FXS). Ganaxolone modulates GABA-A ... Early research suggests that normalizing neurosteroid levels with ganaxolone ...
Cached Medicine Technology:Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 2Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 3Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome 2
70 discs to investigate acquired color deficiency. Quantifies neutral zone characteristics of dyschromatopsia and evaluates the relative luminance....
... 15 disc test (P/N LD15C) include a ... comprehensive instructions. P/N LD15C also includes a ... tip covers for the test subjects fingers ... the color discs). Beware that these finger ...
Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
Opti-Free Express multi-purpose disinfecting solution lasting comfort No Rub formula provides triple action protection for your contact lenses....
Medicine Products: